ELIQUIS
Active substance: apixaban
TABLET, FOR SUSPENSION · APIXABAN .5 mg/1
United StatesActive
Marketing holder: E.R. Squibb & Sons, L.L.C.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- APIXABAN · .5 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 34 |
|
| EU 2 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e17-781e-8aaa-147cceecc1ac,01a120c3-2e37-7d99-92c7-0a3234f99779,01a120c3-43d1-7f9e-9da7-653f59f6dae5,01a120c3-5257-7328-97ca-15de092522c8,01a120c3-541d-7944-94a0-d38f787c74de;count=32 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-060b-7f30-a1cb-b3cb37e969f3,01a1208e-0887-7c3a-975c-4e6a8ed1dd8a,01a1208e-0eaf-7d87-8965-41cd3e46c296,01a1208e-dcdd-7d75-a3e6-08da7e45c01a,01a1208f-33ff-7a9f-ba9f-9de2832d05f5;count=20 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0003-1028
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 0003-1028 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0003-1028 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0003-1028 · Verified 2026-10-09 · open in source